Primary Peritoneal Serous Adenocarcinoma Completed Phase 2 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0030567 (Primary Peritoneal Serous Adenocarcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00888615Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerTreatment